Unusual accumulation of ¹⁷⁷Lu-DOTATATE at the injection site of a COVID-19 vaccination

Keywords

DOTATATE - COVID-19 - vaccination - Lu-177 - radionuclide therapy

Publication History

Received: 10 January 2022

Accepted after revision: 12 May 2022

Article published online:
09 August 2022

• References

• 1 Poeppel TD, Boy C, Bockisch A. et al. Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1). Nuklearmedizin 2015; 54: 1-11
• 2 Anzola LK, Glaudemans AWJM, Dierckx RAJO. et al. Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review. Eur J Nucl Med Mol Imaging 2019; 46: 2496-2513
• 3 Weiler-Sagie M, Half EE. [68Ga]Ga-DOTATATE uptake due to COVID-19 vaccination.. Eur J Nucl Med Mol Imaging 2021; 48: 3743-3744
• 4 Dalm VASH, van Hagen PM, van Koetsveld PM. et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab 2003; 285: E344-E353
• 5 Falcke SE, Rühle PF, Deloch L. et al. Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System. Int J Mol Sci 2018; 19: 3574